Supernus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Supernus Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $0.69 | $0.44 | 56.8 % |
Jun 2024 | 2024-08-06 | $0.36 | $0.39 | -7.69 % |
Mar 2024 | 2024-05-08 | $0 | $0.38 | -100.0 % |
Dec 2023 | 2024-02-27 | $0.39 | $0.55 | -29.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $175.69M | $157.30M | 11.7 % |
Jun 2024 | 2024-08-06 | $168.33M | $148.85M | 13.1 % |
Mar 2024 | 2024-05-08 | $143.64M | $145.83M | -1.50 % |
Dec 2023 | 2024-02-27 | $164.31M | $155.03M | 5.99 % |
Supernus Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2024 for Q3.
Supernus Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2024 for Q3 and the Actual EPS was $0.69, which beat the estimate of $0.44.
Supernus Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.